Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Crit Care Clin. 2020 Oct 28;37(1):135–150. doi: 10.1016/j.ccc.2020.08.006

The Effect of Aging Physiology on Critical Care

Dijoia B Darden 1, Frederick A Moore 2, Scott C Brakenridge 3, Eduardo B Navarro 4, Stephen D Anton 5, Christiaan Leeuwenburgh 6, Lyle L Moldawer 7, Alicia M Mohr 8, Philip A Efron 9, Robert T Mankowski 10
PMCID: PMC8194285  NIHMSID: NIHMS1673947  PMID: 33190766

Introduction

The number of older adults, defined as individuals ≥65 years old, are rapidly increasing in the United States and are projected to reach 84 million by the year 2050 1. Although there is a difference between chronological and physiological aging 2, older adult populations tend to have a weaker physiological phenotype compared to a younger population 3. In addition, older adults account for nearly 50% of intensive care unit (ICU) admissions and 60% of all ICU days. 4,5

One of the main biological processes of systemic deterioration that contributes to development of organ dysfunctions in aging are immunosenescence (age associated gradual deterioration of protective immunity) and inflammaging (chronic subclinical systemic inflammation). Both of these detrimental processes lower the efficacy of the immune system, leading to higher vulnerability to infections and susceptibility to inflammatory conditions 6,7, and thus higher susceptibilities for critical illness and dismal outcomes. 8 Other cellular processes like elevated oxidative stress and apoptosis, as well as declines in autophagy are hallmarks of the aging deterioration process that contribute to susceptibility to infections and worse outcomes in critical illness. 912

Reactive oxygen species are produced in the normal aging process at the cellular level in all systems as mediators of cell differentiation and growth, and are scavenged by anti-oxidant enzymes in order to maintain homeostasis. 13,14 The aging process is associated with a less efficient free radical scavenging process and over-production of free radicals elevating oxidative stress, cell damage and death – necrosis. 15,16 Aging is also associated with a higher level of apoptosis, programmed death and decline in autophagy, a cellular process where dysfunctional and cytotoxic parts of the cell are digested and removed by lysosomes. 17,18 These detrimental processes contribute to the development of comorbidities in older adults such as cardiovascular disease, neurodegenerative diseases, physical disability and cancers.

The main purpose of this review is to briefly summarize the age-specific changes in the main physiologic systems (Figure 1) that occur in critically ill older adults that can have implications in clinical management. Special considerations for clinical management of older patients in the ICU need to be considered 3,5 due to different physiological and biological profile especially when considering the management of sepsis and trauma, that may result in a relatively new phenotype, prevalent in older critical illness survivors, classified as chronic critical illness (CCI). 19

Figure 1.

Figure 1.

Summary of the effect of aging on various physiologic systems.

Brain

Aging is associated with neurodegeneration, neuroinflammation and decreased perfusion of the cerebrovascular circulation that contributes to cognitive decline, dementia and Alzheimer’s Disease.20 Inter-personal degrees of alterations in the brain are highly variable, but the largest changes are observed in the frontal and temporal cortex. The frontal cortex is responsible for attention and memory, and also speech production.21 The temporal cortex is involved in auditory and visual recognition such as language recognition.22 Older adults with pre-existing cognitive impairment are more susceptible to an amplified burden of critical illness leading to delirium in the ICU.23 Delirium is an acute state of confusion that affects majority of older patients and develops within hours or days after the ICU admission and leads to alterations in consciousness and cognition.24 A medical team should distinguish between delirium and dementia or other psychiatric disorders, and implement reduction of factors that triggered delirium and apply medication treatment for those at risk of harming themselves.25

Cardiovascular

Advanced age is associated with a change in cardiac structure such as a loss in the number of myocytes, increased arterial wall thickness, increase in collagen deposition and reduced vascular compliance.26,27 These changes contribute to the higher prevalence of cardiovascular disease (CVD) in older adults such as hypertension, atrial fibrillation, heart failure, myocardial infarction, stroke and peripheral arterial disease. 28,29 However, the addition of the stress of critical illness accentuates the cardiac dysfunction in the elderly requiring special consideration in hemodynamic support in the ICU.30

Coronary artery flow is also diminished in the elderly population, which is secondary to increased prevalence of coronary artery disease, increased arterial wall thickness, and increased pulse pressure. 31,32 During critical illness, these changes lead to increased risk for cardiac ischemia in the elderly. 33 Finally, increased age is also an independent risk factor for the development of arrhythmias as a result of the conduction system dysfunction caused by an increase in collagen, inflammation and fat deposition as well as decreased myocyte number. 3437 New onset atrial fibrillation secondary to acute critical illness is more common in the elderly and is associated with increased mortality in the ICU. 38

During aging, cellular loss and increases in myocardial collagen deposits lead to a decreased response to β-adrenergic stimulation. 39,40 This translates to a decreased heart rate response to stressors. 41 Therefore, the aging heart relies on increasing preload and stroke volume for increase in cardiac output, which makes this population sensitive to hypovolemic states. 26,42 In addition, these changes lead to a diastolic dysfunction, secondary to impaired early left ventricular filling and decreased ventricular compliance.43 Therefore, the critical care practitioner must pay special attention to volume resuscitation in the older adult population. 26 A small amount of hypovolemia can compromise cardiac function, while a small amount of hypervolemia can precipitate pulmonary edema. 26 Bedside transthoracic echocardiography (TTE) has become a very important non-invasive tool and is now routinely used for assessing the cardiac function and hemodynamic evaluation that is utilized in clinical management decisions in older ICU patients.44,45

Pulmonary

Age-related changes in chest wall rigidity and lung parenchyma contribute to decreased respiratory reserve in older adults as well as many ICU related respiratory complications in elderly patients. Chest wall compliance can decrease up to 30% by the age of 75 year old and respiratory muscle strength can decline near 50% in older patients, both ultimately resulting in decreased chest wall expansion. 4,46 The diaphragm also flattens and becomes less efficient. 4749 Full airway expansion cannot occur unless the geriatric patient is in the standing position, which is difficult to achieve in the ICU setting, resulting in a propensity for atelectasis. 48,50 Geriatric patients who are dependent on mechanical ventilation have to work harder because of the diaphragm muscle weakness and decreased chest wall compliance, which can result in difficulties weaning from a ventilator. 51

Aging is also associated with a decreased host response to hypoxemia and hypercapnia. 52 Therefore, with decreased respiratory reserve, older patients are likely to appear normal during respiratory decline and can decompensate very quickly. 4 Decreased alveolar fluid anti-inflammatory proteins and decreased ability for airway clearance resulting in a higher risk of developing pneumonia. 5355 Pneumonia is associated with more complications, frequently requires ICU admission, mechanical ventilation and can lead to death in older adults. 5658 Although the treatment is the same regardless of age, consideration of the above physiology can aid the intensivist in adjuvant treatment and even prevention of pneumonia in their older patients.

Renal

Normal aging is associated with nearly a 45% decrease in glomerular filtration rate secondary to a 50% decrease in renal blood flow and loss of functional parenchyma 59,60. Also, with aging there is an impaired ability to regulate sodium and hydrogen ions, and thus, a decreased ability to manage acid-base status. 61 There is also impaired ability to maximally dilute or concentrate urine that is exacerbated under stress conditions. 62 This renal dysfunction is partially responsible for the inability of older adults to respond to hypovolemia. 61 Additionally, older adult’ kidneys have a decreased filtering ability, and this requires careful consideration for drug levels that are renally excreted and those that can cause nephrotoxicity such as vancomycin, amphotericin B, nonsteroidal anti-inflammatory drugs, or aminoglycosides. 63,64

Age greater than 65 years is an independent risk factor for acute kidney injury (AKI). The cause of this in critically ill aged patients is usually multifactorial with ischemia, hypovolemia, drug or contrast induced nephrotoxicity, and/or acute urinary obstruction often co-existing. 6466 Pre-existing cardiovascular and chronic kidney disease, as well as iatrogenic injury from contrast exposure and various drugs, are among the common causes of AKI in critically ill patients. 67 Also, renal recovery rates are significantly lower in older patients. 66 A recent study suggests that early initiation of renal replacement therapy was associated with increased renal recovery, attenuated kidney-specific and non-kidney organ injury, and decreased risk of all-cause mortality. 68 However, prevention of AKI remains the most important factor in management. 65 Intensivists should maintain appropriate blood pressure and volume status and limit drug and imaging contrast toxicity to reduce increased morbidity and mortality associated with AKI in older patients. 69 Additionally, intensivists should keep in mind that since older patients have lower muscle mass 70,71 and creatinine is formed almost exclusively in the muscles72, creatinine is a less reliable biomarker of baseline renal function and the development of AKI in this population. 73

Gut/Intestine

The intestinal microbiome consists of trillions of organisms and its metabolites, and plays an important role in maintaining the immune system homoeostasis. 74 Importantly, microbiome alterations occur with normal aging as well as contributing to maintaining chronic low-grade inflammation (inflammaging) and immunosenescence. Thus, the microbiome is thought to be involved in the risk for and the development of chronic diseases, as well those conditions associated with these chronic diseases and aging (e.g. sepsis). 75,76

Sepsis is thought to lead to a complete ‘collapse’ of the intestinal microbiome, with an accompanying emergence of a ‘pathobiome’, both of which contribute significantly to the pathology of sepsis. 77 In particular, during aging and in response to critical illness, the gut microbiome loses its microbial diversity. This includes the disappearance of microbes that represent an important part of the microbiota of healthy individuals with anti-inflammatory properties, as well as those producing short-chain fatty acids (SCFAs) from digested fibers, essential metabolites for cellular energy production. 74,78

The aging-related gut microbiome dysbiosis and pathobiome in critical illness have been linked to peripheral organ dysfunctions such as brain, liver, kidney, cardiovascular system, pancreas and skeletal muscle.76 Therefore improving the gut microbiome may be a target to prevent aging-related comorbidities and lowering the susceptibility of these individuals to infections and improving their outcomes to critical illness. 76 For example, gut microbiota can be modulated by supplementing specific beneficial microbial communities deficient in disease states with prebiotics and probiotics as well as fecal microbiota transplantation (FMT).79,80 FMT is thought to supply under-represented microorganisms with probiotics or increasing the diversity of the microbiome and decreasing the pathobiome. Recolonizing particular microbes and the whole microbiota of the older adult host holds promise as approaches to prevent and treat age-related pathological conditions. 78

Skeletal Muscle

Gradual loss of muscle mass, strength and function with aging is natural, but the clinically significant loss of muscle mass and function could be considered as a disease. 81 Sarcopenia is described as a progressive skeletal muscle disorder characterized by decrease in muscle size, fiber composition, number of motor units, and increase of intramuscular fat fibrotic tissue and is associated with increased likelihood of adverse outcomes including falls, fractures, physical disability and mortality 82. Age-related contributing factors to the development of sarcopenia are denervated motor units resulting from disuse atrophy, malnutrition, hormonal changes, and increased of inflammation and oxidative stress. 82

Acute and chronic immune host dysregulation and systemic inflammation contribute to rapid loss of skeletal muscle and lead to the intensive care unit- acquired weakness (ICU-AW). The main risk factors contributing to the development of ICU-AW include the severity of critical illness, immobilization, hyperglycemia, and the use of some medications, including steroids and neuromuscular agents. 83 The pathophysiology of sepsis-induced myopathy involves: mitochondrial dysfunction leading to a bioenergetic failure, oxidative stress and inflammatory cell infiltration protein catabolism, mainly related to an activation of the ubiquitin-proteasome pathway, muscle fibrosis and satellite cell loss and dysfunction. 8486 Satellite cells are progenitor cells that differentiate to myoblasts and fuse to myofibers as part of muscle regeneration. 87 Loss and dysfunction of satellite cells in response to critical illness impairs the regenerative capacity of muscle and ameliorates weaning from the intensive care unit (ICU). 87,88

Given the acute and chronic muscle wasting and impaired regeneration, clinical management should include early post-discharge rehabilitation and nutritional strategies to stimulate anabolic processes and muscle regeneration. Consideration should be given to a high protein diet paired with resistance exercise training, as this therapy combination has been shown to reverse sarcopenia. 89,90

Implications for Clinical Management of Older Trauma Patients

Geriatric trauma accounts for a third of all trauma health care costs in the United States 91. Elderly trauma patients present with worse injuries, have longer hospital stays, and have three times higher mortality rate than young trauma patients. 92 One study demonstrated that geriatric trauma patients that present with severe injuries (ISS>15) and low systolic blood pressure had an odds of 2.16 for mortality compared to young patients with the same injury severity. 93 In a different multi-center cohort study, advanced age was found to be strongly associated with poor outcomes such as severe organ failure, secondary infectious complications, intensive care utilization, ventilator days, and poor discharge disposition or loss of independent living status (long-term acute care facility, skilled nursing facility, hospice etc.). 94 Additionally, elderly trauma patients older than 74 have a 1.67 odds of mortality compared to trauma patients 65–74 years old. 93

Falls are the most common mechanism of injury in geriatric trauma patients. 95 In fact, same level falls are responsible for more severe injury (30-fold) and for an increased cause of death (10-fold) in older adult patients compared to younger cohorts. 96,97 Motor vehicle accidents are the second most common mechanism of injury and the leading cause for mortality in geriatric trauma patients. 98,99

The association of advancing age with increasing frailty has been described as a main contributor to increased risk of short and long term poor outcomes after trauma. 100102 Frailty syndrome is defined as a “decreased reserve and resistance to stressors, resulting from cumulative declines across multiple physiologic systems, and causing vulnerability to adverse outcomes” and can be found in over a third of geriatric trauma patients. 100,102104 Diminished reserves and decreased ability to compensate, as described above, leads to significant morbidity and mortality even with minor injuries after trauma. 97,105107 Diminished respiratory reserve and diminished response to hypoxia and hypercapnia pose a challenge for management of the geriatric patient after chest trauma. 108 Additionally, traditional physiological parameters of Systolic Blood Pressure (SBP) 90 or Heart Rate (HR) > 120 do not accurately reflect clinical decline for elderly trauma patients. 109,110 Therefore, CDC guidelines recommend transport to trauma center for patients ≥ 65 with SBP 110. 111

Implications for Clinical Management of Older Sepsis Patients

Sepsis is the leading cause of death in US hospitals with studies estimating over 5 million deaths per year worldwide. 112,113 There has been an improvement in mortality over the last three decades. 114117 The reduction in short term mortality can be largely credited to the improvements in sepsis screening, evidence-based resuscitation strategies, and standardized critical care, starting with the “Surviving Sepsis Campaign” in 2004. 118 These improvements include increased compliance with evidence-based strategies including early fluid administration, broad-spectrum antibiotic therapy, and vasopressor support to restore end-organ perfusion. 119122 However, older adults continue to have increased susceptibility and mortality to sepsis. 123 One single center study revealed that critically ill patients ≥55 years with sepsis have greater organ dysfunction, 8-fold higher hospital mortality and even higher six month mortality secondary to persistent immunosuppression and catabolism. 124

This predisposition to sepsis in older patients can be partially explained by the aged immune systems inability to mount an effective immune response to pathogens. This is in part due to inflammaging and immunosenescence. 82,125127 Studies in aged humans and mice reveal that the immune dysfunction associated with aging extends to both innate and adaptive immunity. 128130 The aging bone marrow has been noted to produce fewer well-functioning innate cells (e.g. granulocytes, macrophages and dendritic cells) and more immature, less effective myeloid-derived suppressor cells (MDSCs). 131 MDSCs are immature myeloid cells that have the ability to suppress acute inflammatory responses, including lymphocyte proliferation, and resolve inflammation. 132134 Sepsis induces emergency myelopoiesis that amplifies expansion of MDSCs. 133,135137 While younger patients are more capable of returning to a balanced state of innate and adaptive immunity after infection, older patients have difficulty returning to homeostasis. 124,128,138,139 Our ongoing animal and human studies at the University of Florida Sepsis and Critical Illness Research Center suggest that the long-term, persistent MDSC expansion and infiltration resulting from geriatric post-sepsis dys-homeostasis plays a major role in the simultaneous low-grade inflammation (promoting catabolism and anabolic resistance) and immunosuppression (increasing the risk of secondary infections), which is a major contributor to increased morbidity and mortality. 3,124,128,140,141

Chronic Critical Illness as a Result of Improved ICU Care Management

Improvements in critical care for all ages has led to a decline in inpatient mortality. 142,143 Improvements in 30-day mortality after critical illness for trauma and sepsis have led to a larger focus on long-term outcomes, including post-discharge mortality. 19 Among those that survive severe injury or sepsis, there are two clinical trajectories – chronic critical illness (CCI) and rapid recovery (RAP). 144,145 CCI is defined as prolonged intensive care utilization and/or transfer to inpatient facility post-discharge (≥14 days) and persistent organ dysfunction. 146 CCI seems to be driven by a persistence in immune dysfunction. 146148 Many studies have shown a prolonged elevation of circulating inflammatory cytokines and persistent lymphopenia post-sepsis. 133,140,148150 However, older patients are noted have a longer persistence of this pattern of immune dysfunction with higher levels of soluble programmed death ligand (PDL)-1 and decreased absolute lymphocyte counts out to 28 days, while young patients returned to normal levels by day 14. 124

It is estimated that CCI accounts for over $25 billion in health care expenses. 151 Patients over the age of 55 are more likely to have an inpatient disposition (long-term acute care, skilled nursing facilities, inpatient facility, hospice), which is associated with higher one year mortality rates. 100,124,152 Importantly, CCI disproportionately affects elderly patients. 151,153,154 In fact, age ≥55-years has been found to be predictive of CCI after severe trauma. 155

Summary

Although older age is a risk factor for susceptibility to developing critical illness and poor outcomes in the ICU, it is important to recognize that patient’s outcome is still determined primarily by the severity of their critical illness. We have highlighted age-specific changes in physiological systems majorly affected by critical illness (Figure 1), especially as it pertains to sepsis and trauma, which can lead to chronic critical illness. Clinical management decisions should take into account that older adults have lower physiological reserves and impaired immunity and are at high risk of non-recovery from critical illness. Besides customized, life-saving acute clinical management, there is a need for in-hospital and ambulatory interventions to improve the function of the majorly affected systems due to critical illness in older adults, and thus improve in-hospital outcomes, and importantly prevent chronic critical illness.

Synopsis.

Older patients experience a decline in their physiologic reserves as well as chronic low-grade inflammation named ‘inflammaging’. Both of these contribute significantly to aging-related factors that alter the acute, sub-acute and chronic response of these patients to critical illness, such as sepsis. Unfortunately, this altered response to stressors can lead to chronic critical illness followed by dismal outcomes and death. Since the geriatric population is more susceptible to critical illness, it is important to define their unique response to critical illness as well as customize their clinical management. The primary goal of this review is to briefly highlight age-specific changes in physiological systems majorly affected in critical illness, especially as it pertains to sepsis and trauma which can lead to chronic critical illness, and describe implications in clinical management.

Key Points:

  • Older adults demonstrate lower physiological reserves of major organs such as brain, cardio-pulmonary, renal, musculoskeletal and intestinal systems and impaired immunity.

  • Due to lower physiological reserves, older adults are more susceptible to critical illness and are at high risk of poor short-term and long-term outcomes with failure to recover.

  • Intensivists should take into account compromised physiology in the critical care management.

  • In-hospital and ambulatory interventions are needed to improve the function of the majorly affected organs due critical illness in older adults to improve in-hospital outcomes, and importantly prevent chronic critical illness.

Acknowledgements

Funding

Supported, in part, by National Institutes Health grants: American Heart Association 18CDA34080001 (R.T. Mankowski) and National Institutes of General Medical Sciences R01 GM-040586 and R01 GM-104481 (L.L. Moldawer), NIGMS R01 GM-113945 (P.A. Efron), NIGMS P50 GM-111152 (F.A. Moore, S.C. Brakenridge, L.L. Moldawer, P.A. Efron, A.M. Mohr), and in a postgraduate training grant T32 GM-008721 in burns, trauma, and perioperative injury (D.B. Darden).

Footnotes

Disclosure Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Contributor Information

Dijoia B. Darden, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Frederick A. Moore, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Scott C. Brakenridge, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Eduardo B. Navarro, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Stephen D. Anton, Department of Aging and Geriatric Research, University of Florida College of Medicine, Gainesville, Florida, USA.

Christiaan Leeuwenburgh, Department of Aging and Geriatric Research, University of Florida College of Medicine, Gainesville, Florida, USA.

Lyle L. Moldawer, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Alicia M. Mohr, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Philip A. Efron, Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Robert T. Mankowski, Department of Aging and Geriatric Research, University of Florida, 2004 Mowry Road, Gainesville, FL, 32611, United States

References

  • 1.Kingston A, Comas-Herrera A, Jagger C, project M. Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim) modelling study. Lancet Public Health. 2018;3(9):e447–e455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69(6):640–649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mankowski RT, Anton SD, Ghita GL, et al. Older Sepsis Survivors Suffer Persistent Disability Burden and Poor Long-Term Survival. J Am Geriatr Soc. 2020; 10.1111/jgs.16435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Menaker J, Scalea TM. Geriatric care in the surgical intensive care unit. Crit Care Med. 2010;38(9 Suppl):S452–459. [DOI] [PubMed] [Google Scholar]
  • 5.Prescott HC, Angus DC. Enhancing Recovery From Sepsis: A Review. JAMA. 2018;319(1):62–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Schulz AR, Malzer JN, Domingo C, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195(10):4699–4711. [DOI] [PubMed] [Google Scholar]
  • 7.Metcalf TU, Cubas RA, Ghneim K, et al. Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors. Aging Cell. 2015;14(3):421–432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211(2):144–156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Al-Zamil WM, Yassin SA. Recent developments in age-related macular degeneration: a review. Clin Interv Aging. 2017;12:1313–1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Horiguchi H, Loftus TJ, Hawkins RB, et al. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy. Front Immunol. 2018;9:595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Martin TR, Nakamura M, Matute-Bello G. The role of apoptosis in acute lung injury. Crit Care Med. 2003;31(4 Suppl):S184–188. [DOI] [PubMed] [Google Scholar]
  • 12.Tardif N, Polia F, Tjader I, Gustafsson T, Rooyackers O. Autophagy flux in critical illness, a translational approach. Sci Rep. 2019;9(1):10762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Calabrese EJ, Mattson MP. How does hormesis impact biology, toxicology, and medicine? NPJ Aging Mech Dis. 2017;3:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88(Pt B):314–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Khan SS, Singer BD, Vaughan DE. Molecular and physiological manifestations and measurement of aging in humans. Aging Cell. 2017;16(4):624–633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361(15):1475–1485. [DOI] [PubMed] [Google Scholar]
  • 17.Dutta D, Xu J, Dirain ML, Leeuwenburgh C. Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity. Free Radic Biol Med. 2014;74:252–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Marzetti E, Calvani R, Cesari M, et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol. 2013;45(10):2288–2301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gardner AK, Ghita GL, Wang Z, et al. The Development of Chronic Critical Illness Determines Physical Function, Quality of Life, and Long-Term Survival Among Early Survivors of Sepsis in Surgical ICUs. Crit Care Med. 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clin Geriatr Med. 2013;29(4):737–752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gabrieli JD, Poldrack RA, Desmond JE. The role of left prefrontal cortex in language and memory. Proc Natl Acad Sci U S A. 1998;95(3):906–913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry. 2001;58(5):461–465. [DOI] [PubMed] [Google Scholar]
  • 23.Peterson JF, Pun BT, Dittus RS, et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc. 2006;54(3):479–484. [DOI] [PubMed] [Google Scholar]
  • 24.Hayhurst CJ, Pandharipande PP, Hughes CG. Intensive Care Unit Delirium: A Review of Diagnosis, Prevention, and Treatment. Anesthesiology. 2016;125(6):1229–1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bienvenu OJ, Neufeld KJ, Needham DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med. 2012;40(9):2662–2670. [DOI] [PubMed] [Google Scholar]
  • 26.Oxenham H, Sharpe N. Cardiovascular aging and heart failure. Eur J Heart Fail. 2003;5(4):427–434. [DOI] [PubMed] [Google Scholar]
  • 27.Picca A, Mankowski RT, Burman JL, et al. Mitochondrial quality control mechanisms as molecular targets in cardiac ageing. Nat Rev Cardiol. 2018;15(9):543–554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Damluji AA, Forman DE, van Diepen S, et al. Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association. Circulation. 2020;141(2):e6–e32. [DOI] [PubMed] [Google Scholar]
  • 29.Writing Group M, Mozaffarian D, Benjamin EJ, et al. Executive Summary: Heart Disease and Stroke Statistics−−2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):447–454. [DOI] [PubMed] [Google Scholar]
  • 30.Morley JE, Reese SS. Clinical implications of the aging heart. Am J Med. 1989;86(1):77–86. [DOI] [PubMed] [Google Scholar]
  • 31.Benetos A, Waeber B, Izzo J, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens. 2002;15(12):1101–1108. [DOI] [PubMed] [Google Scholar]
  • 32.Joyner MJ. Effect of exercise on arterial compliance. Circulation. 2000;102(11):1214–1215. [DOI] [PubMed] [Google Scholar]
  • 33.Shinmura K Cardiac Senescence, Heart Failure, and Frailty: A Triangle in Elderly People. Keio J Med. 2016;65(2):25–32. [DOI] [PubMed] [Google Scholar]
  • 34.Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–243. [DOI] [PubMed] [Google Scholar]
  • 35.Kim SC, Stice JP, Chen L, et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ Res. 2009;105(12):1186–1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006–3010. [DOI] [PubMed] [Google Scholar]
  • 37.Bellumkonda L, Tyrrell D, Hummel SL, Goldstein DR. Pathophysiology of heart failure and frailty: a common inflammatory origin? Aging Cell. 2017;16(3):444–450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chen AY, Sokol SS, Kress JP, Lat I. New-onset atrial fibrillation is an independent predictor of mortality in medical intensive care unit patients. Ann Pharmacother. 2015;49(5):523–527. [DOI] [PubMed] [Google Scholar]
  • 39.Stratton JR, Cerqueira MD, Schwartz RS, et al. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation. 1992;86(2):504–512. [DOI] [PubMed] [Google Scholar]
  • 40.Jones SA, Boyett MR, Lancaster MK. Declining into failure: the age-dependent loss of the L-type calcium channel within the sinoatrial node. Circulation. 2007;115(10):1183–1190. [DOI] [PubMed] [Google Scholar]
  • 41.Boillot A, Massol J, Maupoil V, et al. Alterations of myocardial and vascular adrenergic receptor-mediated responses in Escherichia coli-induced septic shock in the rat. Crit Care Med. 1996;24(8):1373–1380. [DOI] [PubMed] [Google Scholar]
  • 42.Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012;8(1):143–164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Swinne CJ, Shapiro EP, Lima SD, Fleg JL. Age-associated changes in left ventricular diastolic performance during isometric exercise in normal subjects. Am J Cardiol. 1992;69(8):823–826. [DOI] [PubMed] [Google Scholar]
  • 44.Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Cardiac Ultrasound in the Intensive Care Unit: A Review. Cureus. 2019;11(5):e4612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.McLean AS. Echocardiography in shock management. Crit Care. 2016;20:275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Estenne M, Yernault JC, De Troyer A. Rib cage and diaphragm-abdomen compliance in humans: effects of age and posture. J Appl Physiol (1985). 1985;59(6):1842–1848. [DOI] [PubMed] [Google Scholar]
  • 47.Vaz Fragoso CA, Gill TM. Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function. J Gerontol A Biol Sci Med Sci. 2012;67(3):264–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Watsford ML, Murphy AJ, Pine MJ. The effects of ageing on respiratory muscle function and performance in older adults. J Sci Med Sport. 2007;10(1):36–44. [DOI] [PubMed] [Google Scholar]
  • 49.Polkey MI, Hamnegard CH, Hughes PD, Rafferty GF, Green M, Moxham J. Influence of acute lung volume change on contractile properties of human diaphragm. J Appl Physiol (1985). 1998;85(4):1322–1328. [DOI] [PubMed] [Google Scholar]
  • 50.Kelly NG, McCarter RJ, Barnwell GM. Respiratory muscle stiffness is age- and muscle-specific. Aging (Milano). 1993;5(3):229–238. [DOI] [PubMed] [Google Scholar]
  • 51.Aghasafari P, Heise RL, Reynolds A, Pidaparti RM. Aging Effects on Alveolar Sacs Under Mechanical Ventilation. J Gerontol A Biol Sci Med Sci. 2019;74(2):139–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Kronenberg RS, Drage CW. Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J Clin Invest. 1973;52(8):1812–1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Moliva JI, Rajaram MV, Sidiki S, et al. Molecular composition of the alveolar lining fluid in the aging lung. Age (Dordr). 2014;36(3):9633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ho JC, Chan KN, Hu WH, et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 2001;163(4):983–988. [DOI] [PubMed] [Google Scholar]
  • 55.Svartengren M, Falk R, Philipson K. Long-term clearance from small airways decreases with age. Eur Respir J. 2005;26(4):609–615. [DOI] [PubMed] [Google Scholar]
  • 56.Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165(6):766–772. [DOI] [PubMed] [Google Scholar]
  • 57.Tong S, Amand C, Kieffer A, Kyaw MH. Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014. BMC Health Serv Res. 2018;18(1):715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Fry AM, Shay DK, Holman RC, Curns AT, Anderson LJ. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002. JAMA. 2005;294(21):2712–2719. [DOI] [PubMed] [Google Scholar]
  • 59.Denic A, Lieske JC, Chakkera HA, et al. The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. J Am Soc Nephrol. 2017;28(1):313–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Fuiano G, Sund S, Mazza G, et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int. 2001;59(3):1052–1058. [DOI] [PubMed] [Google Scholar]
  • 61.Musso CG. Geriatric nephrology and the ‘nephrogeriatric giants’. Int Urol Nephrol. 2002;34(2):255–256. [DOI] [PubMed] [Google Scholar]
  • 62.Sands JM. Urine concentrating and diluting ability during aging. J Gerontol A Biol Sci Med Sci. 2012;67(12):1352–1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Denic A, Mathew J, Lerman LO, et al. Single-Nephron Glomerular Filtration Rate in Healthy Adults. N Engl J Med. 2017;376(24):2349–2357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Musso CG, Liakopoulos V, Ioannidis I, Eleftheriadis T, Stefanidis I. Acute renal failure in the elderly: particular characteristics. Int Urol Nephrol. 2006;38(3–4):787–793. [DOI] [PubMed] [Google Scholar]
  • 65.Baldea AJ. Effect of aging on renal function plus monitoring and support. Surg Clin North Am. 2015;95(1):71–83. [DOI] [PubMed] [Google Scholar]
  • 66.Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis. 2008;52(2):262–271. [DOI] [PubMed] [Google Scholar]
  • 67.Cheung CM, Ponnusamy A, Anderton JG. Management of acute renal failure in the elderly patient: a clinician’s guide. Drugs Aging. 2008;25(6):455–476. [DOI] [PubMed] [Google Scholar]
  • 68.Wang C, Lv LS, Huang H, et al. Initiation time of renal replacement therapy on patients with acute kidney injury: A systematic review and meta-analysis of 8179 participants. Nephrology (Carlton). 2017;22(1):7–18. [DOI] [PubMed] [Google Scholar]
  • 69.Chronopoulos A, Rosner MH, Cruz DN, Ronco C. Acute kidney injury in elderly intensive care patients: a review. Intensive Care Med. 2010;36(9):1454–1464. [DOI] [PubMed] [Google Scholar]
  • 70.Lynch GS. Update on emerging drugs for sarcopenia - age-related muscle wasting. Expert Opin Emerg Drugs. 2008;13(4):655–673. [DOI] [PubMed] [Google Scholar]
  • 71.Moretti C, Frajese GV, Guccione L, et al. Androgens and body composition in the aging male. J Endocrinol Invest. 2005;28(3 Suppl):56–64. [PubMed] [Google Scholar]
  • 72.Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983;37(3):478–494. [DOI] [PubMed] [Google Scholar]
  • 73.Coca SG. Acute kidney injury in elderly persons. Am J Kidney Dis. 2010;56(1):122–131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535(7610):75–84. [DOI] [PubMed] [Google Scholar]
  • 75.Grosicki GJ, Fielding RA, Lustgarten MS. Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis. Calcif Tissue Int. 2018;102(4):433–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Haak BW, Wiersinga WJ. The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol. 2017;2(2):135–143. [DOI] [PubMed] [Google Scholar]
  • 77.Alverdy JC, Krezalek MA. Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of Sepsis. Crit Care Med. 2017;45(2):337–347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Haak BW, Prescott HC, Wiersinga WJ. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis. Front Immunol. 2018;9:2042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Nakov R, Segal JP, Settanni CR, et al. Microbiome: what intensivists should know. Minerva Anestesiol. 2020. [DOI] [PubMed] [Google Scholar]
  • 80.Cook DJ, Johnstone J, Marshall JC, et al. Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trial. Trials. 2016;17:377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Curtis E, Litwic A, Cooper C, Dennison E. Determinants of Muscle and Bone Aging. J Cell Physiol. 2015;230(11):2618–2625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Brummel NE, Balas MC, Morandi A, Ferrante LE, Gill TM, Ely EW. Understanding and reducing disability in older adults following critical illness. Crit Care Med. 2015;43(6):1265–1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Jolley SE, Bunnell AE, Hough CL. ICU-Acquired Weakness. Chest. 2016;150(5):1129–1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591–1600. [DOI] [PubMed] [Google Scholar]
  • 85.Hasselgren PO, Alamdari N, Aversa Z, Gonnella P, Smith IJ, Tizio S. Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation. Curr Opin Clin Nutr Metab Care. 2010;13(4):423–428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Klaude M, Fredriksson K, Tjader I, et al. Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond). 2007;112(9):499–506. [DOI] [PubMed] [Google Scholar]
  • 87.Rocheteau P, Chatre L, Briand D, et al. Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nat Commun. 2015;6:10145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Dos Santos C, Hussain SN, Mathur S, et al. Mechanisms of Chronic Muscle Wasting and Dysfunction after an Intensive Care Unit Stay. A Pilot Study. Am J Respir Crit Care Med. 2016;194(7):821–830. [DOI] [PubMed] [Google Scholar]
  • 89.Liao CD, Tsauo JY, Wu YT, et al. Effects of protein supplementation combined with resistance exercise on body composition and physical function in older adults: a systematic review and meta-analysis. Am J Clin Nutr. 2017;106(4):1078–1091. [DOI] [PubMed] [Google Scholar]
  • 90.Phillips SM, Dickerson RN, Moore FA, Paddon-Jones D, Weijs PJ. Protein Turnover and Metabolism in the Elderly Intensive Care Unit Patient. Nutr Clin Pract. 2017;32(1_suppl):112S–120S. [DOI] [PubMed] [Google Scholar]
  • 91.Weir S, Salkever DS, Rivara FP, Jurkovich GJ, Nathens AB, Mackenzie EJ. One-year treatment costs of trauma care in the USA. Expert Rev Pharmacoecon Outcomes Res. 2010;10(2):187–197. [DOI] [PubMed] [Google Scholar]
  • 92.Keller JM, Sciadini MF, Sinclair E, O’Toole RV. Geriatric trauma: demographics, injuries, and mortality. J Orthop Trauma. 2012;26(9):e161–165. [DOI] [PubMed] [Google Scholar]
  • 93.Hashmi A, Ibrahim-Zada I, Rhee P, et al. Predictors of mortality in geriatric trauma patients: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2014;76(3):894–901. [DOI] [PubMed] [Google Scholar]
  • 94.Vanzant EL, Hilton RE, Lopez CM, et al. Advanced age is associated with worsened outcomes and a unique genomic response in severely injured patients with hemorrhagic shock. Crit Care. 2015;19:77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Labib N, Nouh T, Winocour S, et al. Severely injured geriatric population: morbidity, mortality, and risk factors. J Trauma. 2011;71(6):1908–1914. [DOI] [PubMed] [Google Scholar]
  • 96.Bergeron E, Clement J, Lavoie A, et al. A simple fall in the elderly: not so simple. J Trauma. 2006;60(2):268–273. [DOI] [PubMed] [Google Scholar]
  • 97.Sterling DA, O’Connor JA, Bonadies J. Geriatric falls: injury severity is high and disproportionate to mechanism. J Trauma. 2001;50(1):116–119. [DOI] [PubMed] [Google Scholar]
  • 98.Bonne S, Schuerer DJ. Trauma in the older adult: epidemiology and evolving geriatric trauma principles. Clin Geriatr Med. 2013;29(1):137–150. [DOI] [PubMed] [Google Scholar]
  • 99.Lee WY, Cameron PA, Bailey MJ. Road traffic injuries in the elderly. Emerg Med J. 2006;23(1):42–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Joseph B, Orouji Jokar T, Hassan A, et al. Redefining the association between old age and poor outcomes after trauma: The impact of frailty syndrome. J Trauma Acute Care Surg. 2017;82(3):575–581. [DOI] [PubMed] [Google Scholar]
  • 101.Joseph B, Pandit V, Zangbar B, et al. Validating trauma-specific frailty index for geriatric trauma patients: a prospective analysis. J Am Coll Surg. 2014;219(1):10–17 e11. [DOI] [PubMed] [Google Scholar]
  • 102.Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–156. [DOI] [PubMed] [Google Scholar]
  • 103.Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54(6):991–1001. [DOI] [PubMed] [Google Scholar]
  • 104.Hamerman D Toward an understanding of frailty. Ann Intern Med. 1999;130(11):945–950. [DOI] [PubMed] [Google Scholar]
  • 105.Bardes JM, Benjamin E, Schellenberg M, Inaba K, Demetriades D. Old Age With a Traumatic Mechanism of Injury Should Be a Trauma Team Activation Criterion. J Emerg Med. 2019;57(2):151–155. [DOI] [PubMed] [Google Scholar]
  • 106.Caterino JM, Valasek T, Werman HA. Identification of an age cutoff for increased mortality in patients with elderly trauma. Am J Emerg Med. 2010;28(2):151–158. [DOI] [PubMed] [Google Scholar]
  • 107.Demetriades D, Sava J, Alo K, et al. Old age as a criterion for trauma team activation. J Trauma. 2001;51(4):754–756; discussion 756–757. [DOI] [PubMed] [Google Scholar]
  • 108.Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Heffernan DS, Thakkar RK, Monaghan SF, et al. Normal presenting vital signs are unreliable in geriatric blunt trauma victims. J Trauma. 2010;69(4):813–820. [DOI] [PubMed] [Google Scholar]
  • 110.Martin JT, Alkhoury F, O’Connor JA, Kyriakides TC, Bonadies JA. ‘Normal’ vital signs belie occult hypoperfusion in geriatric trauma patients. Am Surg. 2010;76(1):65–69. [PubMed] [Google Scholar]
  • 111.Sasser SM, Hunt RC, Faul M, et al. Guidelines for field triage of injured patients: recommendations of the National Expert Panel on Field Triage, 2011. MMWR Recomm Rep. 2012;61(RR-1):1–20. [PubMed] [Google Scholar]
  • 112.Center for Disease Control and Prevention. Sepsis, Data & Reports. 2016; https://www.cdc.gov/sepsis/datareports/index.html. Accessed 10 April 2020.
  • 113.Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. [DOI] [PubMed] [Google Scholar]
  • 114.Fleischmann C, Thomas-Rueddel DO, Hartmann M, et al. Hospital Incidence and Mortality Rates of Sepsis. Dtsch Arztebl Int. 2016;113(10):159–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Kumar G, Kumar N, Taneja A, et al. Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest. 2011;140(5):1223–1231. [DOI] [PubMed] [Google Scholar]
  • 116.Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554. [DOI] [PubMed] [Google Scholar]
  • 117.Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med. 2014;42(3):625–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30(4):536–555. [DOI] [PubMed] [Google Scholar]
  • 119.Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010;38(4):1036–1043. [DOI] [PubMed] [Google Scholar]
  • 120.Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care. 2005;9(6):R764–770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015;43(1):3–12. [DOI] [PubMed] [Google Scholar]
  • 122.Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015;41(9):1620–1628. [DOI] [PubMed] [Google Scholar]
  • 123.Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310. [DOI] [PubMed] [Google Scholar]
  • 124.Brakenridge SC, Efron PA, Stortz JA, et al. The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients. J Trauma Acute Care Surg. 2018;85(2):247–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Pinheiro da Silva F, Machado MCC. Septic Shock and the Aging Process: A Molecular Comparison. Front Immunol. 2017;8:1389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Baldwin MR. Measuring and predicting long-term outcomes in older survivors of critical illness. Minerva Anestesiol. 2015;81(6):650–661. [PMC free article] [PubMed] [Google Scholar]
  • 127.Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity. 2006;24(5):491–494. [DOI] [PubMed] [Google Scholar]
  • 128.Nacionales DC, Gentile LF, Vanzant E, et al. Aged mice are unable to mount an effective myeloid response to sepsis. J Immunol. 2014;192(2):612–622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Cao JN, Gollapudi S, Sharman EH, Jia Z, Gupta S. Age-related alterations of gene expression patterns in human CD8+ T cells. Aging Cell. 2010;9(1):19–31. [DOI] [PubMed] [Google Scholar]
  • 130.Tarazona R, DelaRosa O, Alonso C, et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2000;121(1–3):77–88. [DOI] [PubMed] [Google Scholar]
  • 131.Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2010;1(2):147–157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Stortz JA, Mira JC, Raymond SL, et al. Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients. J Trauma Acute Care Surg. 2018;84(2):342–349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Mathias B, Delmas AL, Ozrazgat-Baslanti T, et al. Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock. Ann Surg. 2017;265(4):827–834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Cuenca AG, Moldawer LL. Myeloid-derived suppressor cells in sepsis: friend or foe? Intensive Care Med. 2012;38(6):928–930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Darcy CJ, Minigo G, Piera KA, et al. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care. 2014;18(4):R163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Delano MJ, Scumpia PO, Weinstein JS, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med. 2007;204(6):1463–1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Janols H, Bergenfelz C, Allaoui R, et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol. 2014;96(5):685–693. [DOI] [PubMed] [Google Scholar]
  • 138.Nacionales DC, Szpila B, Ungaro R, et al. A Detailed Characterization of the Dysfunctional Immunity and Abnormal Myelopoiesis Induced by Severe Shock and Trauma in the Aged. J Immunol. 2015;195(5):2396–2407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Bueno V, Sant’Anna OA, Lord JM. Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease. Age (Dordr). 2014;36(6):9729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Hollen MK, Stortz JA, Darden D, et al. Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis. Crit Care. 2019;23(1):355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Mira JC, Brakenridge SC, Moldawer LL, Moore FA. Persistent Inflammation, Immunosuppression and Catabolism Syndrome. Crit Care Clin. 2017;33(2):245–258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. [DOI] [PubMed] [Google Scholar]
  • 143.Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. 2012;60(6):1070–1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Lamas D Chronic critical illness. N Engl J Med. 2014;370(2):175–177. [DOI] [PubMed] [Google Scholar]
  • 145.Cox CE. Persistent systemic inflammation in chronic critical illness. Respir Care. 2012;57(6):859–864; discussion 864–856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Hawkins RB, Raymond SL, Stortz JA, et al. Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Front Immunol. 2018;9:1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Efron PA, Mohr AM, Bihorac A, et al. Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery. Surgery. 2018;164(2):178–184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Mira JC, Gentile LF, Mathias BJ, et al. Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome. Crit Care Med. 2017;45(2):253–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Minejima E, Bensman J, She RC, et al. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia. Crit Care Med. 2016;44(4):671–679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014;42(5):383–391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Kahn JM, Le T, Angus DC, et al. The epidemiology of chronic critical illness in the United States*. Crit Care Med. 2015;43(2):282–287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Davidson GH, Hamlat CA, Rivara FP, Koepsell TD, Jurkovich GJ, Arbabi S. Long-term survival of adult trauma patients. JAMA. 2011;305(10):1001–1007. [DOI] [PubMed] [Google Scholar]
  • 153.Nelson JE, Cox CE, Hope AA, Carson SS. Chronic critical illness. Am J Respir Crit Care Med. 2010;182(4):446–454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Carson SS, Bach PB. The epidemiology and costs of chronic critical illness. Crit Care Clin. 2002;18(3):461–476. [DOI] [PubMed] [Google Scholar]
  • 155.Mira JC, Cuschieri J, Ozrazgat-Baslanti T, et al. The Epidemiology of Chronic Critical Illness After Severe Traumatic Injury at Two Level-One Trauma Centers. Crit Care Med. 2017;45(12):1989–1996. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES